-transparent.png){kind=logo}
The effect of indomethacin on heterotopic and orthotopic bone formation in rats was analyzed with respect to dose and time of initiation of drug administration. Three weeks after implantation of demineralized bone matrix, the ash weight of implants from animals receiving the highest doses of indomethacin was approximately 25% lower than that of controls. The ash weight of implants was only affected in rats receiving indomethacin from the week before implantation or from the time of implantation. In a separate study, no effect on the rate of resorption measured by elimination of 3H-proline and 45Ca or on the amount of ash could be detected. Orthotopic bone remained unaffected by indomethacin treatment. The study showed that in order to inhibit experimental new bone formation, indomethacin must be present before or at the time of implantation of demineralized bone matrix.
H Törnkvist, and
F C Bauer, and
O S Nilsson
January 1988,
Revue de chirurgie orthopedique et reparatrice de l'appareil moteur,
H Törnkvist, and
F C Bauer, and
O S Nilsson
April 1996,
Calcified tissue international,
H Törnkvist, and
F C Bauer, and
O S Nilsson
January 2007,
Scandinavian journal of clinical and laboratory investigation,
H Törnkvist, and
F C Bauer, and
O S Nilsson
October 1990,
Anales de medicina interna (Madrid, Spain : 1984),
H Törnkvist, and
F C Bauer, and
O S Nilsson
December 2002,
Journal of applied physiology (Bethesda, Md. : 1985),
H Törnkvist, and
F C Bauer, and
O S Nilsson
January 1984,
Clinical orthopaedics and related research,
H Törnkvist, and
F C Bauer, and
O S Nilsson
January 1989,
Pharmaceutical research,
H Törnkvist, and
F C Bauer, and
O S Nilsson
December 1975,
JPMA. The Journal of the Pakistan Medical Association,
H Törnkvist, and
F C Bauer, and
O S Nilsson
September 1997,
Journal of experimental & clinical cancer research : CR,
H Törnkvist, and
F C Bauer, and
O S Nilsson
January 1998,
Archives of orthopaedic and trauma surgery,
